LOS ANGELES, Nov. 28, 2016 /PRNewswire/ -- Global Health Solutions has announced 510k FDA approval of PolyPlex Wound Dressing,a first of its kind, petrolatum based topical gel indicated for acute and chronic wound management. PolyPlex Wound Dressing employs Global Health Solutions' proprietary PermaFusion delivery system, first employed in its initial product offering, CurX
Chronic wounds represent a significant burden to patients and practitioners, as well as the United States healthcare system, affecting 5.7 million patients and costing an estimated 20 billion dollars, annually. Glenn Mattes, Executive Chair of Global Health Solutions, states: "The approval and introduction of PolyPlex will provide practitioners with an important new wound management tool suitable for a multitude of patient types. We plan to aggressively market and sell PolyPlex, as well continue to develop and introduce additional products to this market."
PolyPlex Wound Dressing will be available in January of 2017 through McKesson Medical-Surgical. For more information, contact your McKesson account manager or visit www.globalhealthrx.com.
About Global Health Solutions
Global Health Solutions is a mid-sized pharmaceutical and device manufacturing organization with principal offices in Georgia. Global Health Solutions is dedicated to reducing loss of limb and life through novel, best in class, advanced wound care technologies that maximize outcome and minimize risk.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-health-solutions-announces-510k-fda-approval-of-polyplex-wound-dressing-300368764.html
SOURCE Global Health Solutions
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All